-

Mexedia Initiates Evaluations of Potential Industrial Development Initiatives

ROME--(BUSINESS WIRE)--Regulatory News:

Mexedia S.p.A. announces that it is currently evaluating potential development initiatives, including through discussions with operators active in its sector of reference

Share

Mexedia S.p.A. Società Benefit (Euronext Growth Paris: ALMEX, ISIN: IT0005450819), as part of its industrial evolution and the strengthening of its operating structure, announces that it is currently evaluating potential development initiatives, including through discussions with operators active in its sector of reference.

These discussions are part of a progressive focus on core activities and an improvement in revenue quality, in line with the actions initiated in 2024 and continued in 2025, which have contributed to making the Group’s operating framework more efficient and solid. The initiatives under review are aimed at identifying opportunities consistent with this evolution, with the objective of consolidating existing activities and improving the Group’s economic and financial profile, while maintaining a selective approach.

The ongoing evaluations are part of this broader context and are expected to evolve over the coming months, depending on market conditions and ongoing analyses. The activities are currently under evaluation and no binding commitments have been entered into. The market will be informed in the event of any material developments, in accordance with applicable regulations.

Paolo Bona, Chief Executive Officer of Mexedia S.p.A. Società Benefit, commented:“During 2025, the Group undertook a process of rationalization and increased focus on its activities, which contributed to an improvement in operating performance. In this context, we continue to evaluate potential development initiatives, maintaining a selective approach consistent with the path undertaken. Any potential transactions will be assessed based on their ability to strengthen the Group’s operating structure and to progressively improve its economic and financial profile.”

Mexedia intends to continue along this direction, with an approach focused on the quality of its activities, operational efficiency and the progressive consolidation of its economic and financial structure, in line with its medium- to long-term development objectives.

Forward-Looking Statements (MAR)

This press release may contain forward-looking statements within the meaning of Regulation (EU) No. 596/2014 (“MAR”) and other applicable regulations. Such statements reflect expectations and projections regarding future events and the Group’s performance and are subject to risks and uncertainties that may cause actual results to differ materially from those expressed or implied.

About Mexedia

Mexedia S.p.A. Società Benefit is a technology company listed in France on Euronext Growth Paris (ISIN: IT0005450819, ticker: ALMEX) since September 2021, active in technology services and communication solutions. The Group operates internationally and develops industrial models aimed at creating value over the medium to long term. As a Benefit Company, Mexedia combines economic growth objectives with social and environmental impact goals, pursuing sustainable value creation over time.

Contacts

Investor Relations Contacts

Vincenzo La Barbera
investor.relations@mexedia.com
+39 351 844 722

Mexedia S.p.A. Società Benefit

BOURSE:ALMEX
Details
Headquarters: Rome, Italy
CEO: Paolo Bona
Employees: 10
Organization: PUB

Release Versions

Contacts

Investor Relations Contacts

Vincenzo La Barbera
investor.relations@mexedia.com
+39 351 844 722

More News From Mexedia S.p.A. Società Benefit

Mexedia S.p.A. : Admission to Trading of the New Shares Issued Under the First Tranche of the Capital Increase Reserved to Likan AG

ROME--(BUSINESS WIRE)--Regulatory News: Mexedia S.p.A. Società Benefit (Euronext Growth Paris: ALMEX, ISIN: IT0005450819, the “Company”), further to its press releases of 28 and 29 October 2026, announces the admission to trading on Euronext Growth Paris of 1,000,000 new ordinary shares (the “New Shares”) issued under the first tranche of the capital increase reserved to Likan AG (the “Investor”). The Transaction As announced to the market on 29 October 2026, the Company signed with the Investo...

Mexedia Signs a Fixed-price Equity Investment Agreement With Likan AG for up to EUR 20 Million

ROME, Italy--(BUSINESS WIRE)--Regulatory News: Mexedia S.p.A. Società Benefit (Euronext Growth Paris: ALMEX, ISIN: IT0005450819, the “Company”) announces that, upon implementation of the resolution adopted by the Extraordinary Shareholders’ Meeting of 28 October 2026, it has signed today an investment agreement (the “Agreement”) with Likan AG, a company incorporated under Swiss law with registered office in Zug (the “Investor”), under which the Investor undertakes to subscribe for newly issued...

MEXEDIA S.p.A. Società Benefit Half-Year Results 2026: New Operating Perimeter and Significant Reduction in Net Financial Debt

ROME--(BUSINESS WIRE)--Regulatory News: The Board of Directors of Mexedia S.p.A. Società Benefit (Euronext Growth Paris: ALMEX — ISIN IT0005450819) met today and approved the unaudited consolidated results for the first half of 2026. The unaudited Consolidated Half-Year Financial Report as at 30 June 2026 will be made available to the public by 30 October 2026, in line with the Company's financial calendar. A half-year marked by the redefinition of the Group’s perimeter The first half of 2026 r...
Back to Newsroom